Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
2.000
-0.120 (-5.66%)
Oct 30, 2025, 9:30 AM EDT - Market open
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $266.01 million as of October 30, 2025. Its market cap has increased by 6,550.13% in one year.
Market Cap
266.01M
Enterprise Value
276.87M
1-Year Change
6,550.13%
Ranking
Category
Stock Price
$2.00
Market Cap Chart
Since March 30, 2007, Palisade Bio's market cap has increased from $82.40M to $266.01M, an increase of 222.82%. That is a compound annual growth rate of 6.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 19.30M | 777.27% |
| Dec 31, 2024 | 2.20M | -59.26% |
| Dec 29, 2023 | 5.40M | -32.50% |
| Dec 30, 2022 | 8.00M | -54.55% |
| Dec 31, 2021 | 17.60M | 15.79% |
| Dec 31, 2020 | 15.20M | 300.00% |
| Dec 31, 2019 | 3.80M | -33.33% |
| Dec 31, 2018 | 5.70M | -78.08% |
| Dec 29, 2017 | 26.00M | -16.13% |
| Dec 30, 2016 | 31.00M | -67.02% |
| Dec 31, 2015 | 94.00M | -60.62% |
| Dec 31, 2014 | 238.70M | 6.23% |
| Dec 31, 2013 | 224.70M | 203.65% |
| Dec 31, 2012 | 74.00M | 55.14% |
| Dec 30, 2011 | 47.70M | -51.92% |
| Dec 31, 2010 | 99.20M | 57.96% |
| Dec 31, 2009 | 62.80M | 20.54% |
| Dec 31, 2008 | 52.10M | -54.10% |
| Dec 31, 2007 | 113.50M | 37.74% |
| Mar 30, 2007 | 82.40M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.90B |
| Johnson & Johnson | 457.53B |
| AbbVie | 402.83B |
| UnitedHealth Group | 331.46B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.35B |